Sales were 6.34 billion yen, up 5.5% year over year. Operating income was 585 million yen (up 0.5%), ordinary income 608 million yen (down 1.2%), and net income attributable to owners of the parent 415 million yen (down 0.8%). Full-year guidance is unchanged. Chemicals segment performed well, while Healthcare slowed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4465","jir_company_name":"Niitaka Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4465-20260925-01.pdf","jir_short_summary":"Sales were 6.34 billion yen, up 5.5% year over year. Operating income was 585 million yen (up 0.5%), ordinary income 608 million yen (down 1.2%), and net income attributable to owners of the parent 415 million yen (down 0.8%). Full-year guidance is unchanged. Chemicals segment performed well, while Healthcare slowed.","jir_summary":"### Summary of Business Results\nFor the first quarter of the consolidated fiscal year, net sales were 6.334 billion yen, up 5.5% year over year, and the business showed solid performance. However, impact from a slowdown in the Healthcare segment and higher raw material costs persisted, resulting in operating income of 58.5 million yen (up 0.5%), ordinary income of 60.8 million yen (down 1.2%), and net income attributable to owners of the parent of 41.5 million yen (down 0.8%). By segment, the Chemicals business expanded, while Healthcare saw a substantial decline in revenue and profit. Full-year guidance remains unchanged. No notable changes regarding share buyback in the body text.\n\n### Financial Position and Outlook\nTotal assets decreased from the end of the previous term, while net assets fluctuated mainly due to an increase in net income for the period and the effects of dividends and share buybacks. The financial structure is solid, but the underperformance of Healthcare is a concern. No change to the full-year earnings guidance. Going forward, trends in raw material costs and domestic and international demand recovery are expected to be key drivers of performance.","jir_financial_highlights":"Sales: 6,334 million yen (YoY 5.5% increase)\nOperating income: 585 million yen (YoY 0.5% increase)\nOrdinary income: 608 million yen (YoY 1.2% decrease)\nNet income attributable to owners of the parent: 415 million yen (YoY 0.8% decrease)\nEarnings per share: 71.00 yen (Compared with the same quarter of the previous year 0.00%)\nTotal assets: 23,181 million yen (Compared with the end of the previous term \u2212659 million yen)\nEquity ratio: 70.0% (Compared with the previous term +1.8 pt)","jir_category":"","jir_hashtags":"#Niitaka, #Earnings, #FinancialHighlights","jir_key_figures":"Sales: 63,340 million yen (YoY +5.5%)\nOperating income: 585 million yen (YoY +0.5%)\nNet income attributable to owners of the parent: 415 million yen (YoY \u22120.8%)","jir_meta_title":"Niitaka: Fiscal Year Ending May 2027, First Quarter Financial Summary | Net sales 6.334 billion yen, Operating income 585 million yen","jir_meta_description":"Overview of Niitaka's first quarter financial results for the fiscal year ending May 2027. Net sales increased 5.5% YoY, operating income slightly higher, with concerns over Healthcare slowdown. Full-year guidance unchanged.","jir_og_title":"Key Points from the First Quarter Financial Summary","jir_og_description":"Niitaka's first quarter results show sales up in the 5% range with Healthcare slowdown impacting earnings. Full-year outlook unchanged.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58419,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-123176","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n